资讯
16 小时
24/7 Wall St. on MSNPrediction: 1 Biotech Stock That Could Surpass Pfizer by 2030Pfizer (NYSE:PFE) is a global pharmaceutical giant that has long been a cornerstone of medical innovation and today boasts a ...
CHICAGO (Reuters) -Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA ...
The project is starting with a $240,000 grant from Alumbra, a foundation established by billionaire Christy Walton ...
Peter Loftus is a reporter for The Wall Street Journal in Philadelphia covering the pharmaceutical and medical-device ...
Novavax's closely watched COVID-19 vaccine is on track for full approval after additional discussions with the Food and Drug Administration, the company said Wednesday. The news sent company shares ...
Long a lobbying powerhouse in Washington, pharma’s struggling to settle on a strategy for defending itself, according to six industry lobbyists and three company officials who spoke to POLITICO. All ...
Having significant capital in the bank when investing in equities is helpful, but is by no means necessary. If you're patient ...
The danger of misrepresenting new malpractice regulations as muzzling doctors’ opinions On Saturday October 8, The Australian published an op-ed titled: “Health disgrace: bureaucrats in bid to silence ...
20 小时
Zacks.com on MSNSanofi Q1 Earnings Top Estimates, Dupixent Drives Sales GrowthDetailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.
A middle school student north of Dallas has tested positive. Meanwhile, Illinois has confirmed its first case in the state. Plus: A study in mice shows that covid is still contagious a week or more ...
Big Pharma, long a lobbying powerhouse in Washington, is struggling to settle on a strategy for defending itself against ...
The audience doesn’t let you be delusional,” Whitney Cummings once said. “They just call bullshit on you. You have to learn ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果